TEHRAN, Dec. 30 (MNA) � Researchers in the Mashhad University of Medical Sciences Center for Genetic Research has developed a new method for treating gastrointestinal cancers.
Dr. Mohammad Reza Abbaszadegan, the project senior researcher told Mehr News that the research was carried out on factors contributing to esophagus cancer. �The method works through molecular interventions of the factors,� he said. �We examined two factors of somatic cells (specifically esophagus epithelial cells), which would turn into fundamental malignant tumors,� he added, �The study was carried out on a sample population of patients diagnosed with esophagus cancer.�

�We found that a high percent of patients had the factor, including Mastermind and Twist 1 factors,� he said. �The second phase of the research would examine whether this method would stop the growth of cancer cells, where we found some success,� said the senior researcher.

The head of Mashhad University of Medical Sciences Center for Genetic Research also pointed to the side-effects of non-specific treatment such as chemotherapy and radiotherapy. �General strands of treatment have side-effects on patients, while the preset method is a specifically biological method,� he said.

�The research findings would find applications in the treatment of larger intestine cancers,� he added.

By Mehr News Agency

 

The Iran Project is not responsible for the content of quoted articles.